Valuation Kobayashi Pharmaceutical Co., Ltd. Deutsche Boerse AG

Stocks

KOY

JP3301100008

Personal Products

Market Closed - 09:02:54 18/08/2026 +03 5-day change 1st Jan Change
28.80 EUR -0.69% Intraday chart for Kobayashi Pharmaceutical Co., Ltd. -3.36% +0.70%

Company Valuation: Kobayashi Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 704,427 650,295 503,841 463,131 403,511 408,937 - -
Change - -7.68% -22.52% -8.08% -12.87% 1.34% - -
Enterprise Value (EV) 1 596,011 546,554 424,992 398,232 333,575 351,075 339,138 333,266
Change - -8.3% -22.24% -6.3% -16.24% 5.25% -3.4% -1.73%
P/E 35.8x 34.8x 25.3x 46x 110x 40.2x 30.1x 24.4x
PBR 3.59x 3.47x 2.47x 2.18x 1.92x 1.94x 1.89x 1.83x
PEG - 12.08x 7.7x -0.9x -1.7x 0x 0.9x 1x
Capitalization / Revenue 4.54x 3.91x 2.9x 2.8x 2.43x 2.37x 2.27x 2.19x
EV / Revenue 3.84x 3.29x 2.45x 2.4x 2.01x 2.03x 1.89x 1.79x
EV / EBITDA 19.3x 17.1x 13.3x 12.1x 14.1x 15.8x 12.5x 10.7x
EV / EBIT 22.9x 20.5x 16.5x 16x 22.4x 26.7x 19.4x 15.5x
EV / FCF 31.8x 31.1x -350x -29.2x 68.5x 24.1x 22.2x 19.4x
FCF Yield 3.15% 3.22% -0.29% -3.42% 1.46% 4.14% 4.51% 5.17%
Dividend per Share 2 83 90 101 102 104 106 109.5 114.3
Rate of return 0.92% 1% 1.49% 1.64% 1.92% 1.93% 1.99% 2.08%
EPS 2 252.4 259.6 268.2 135.4 49.19 137 182.5 225.4
Distribution rate 32.9% 34.7% 37.7% 75.3% 211% 77.4% 60% 50.7%
Net sales 1 155,252 166,258 173,455 165,600 165,742 172,560 179,820 186,639
EBITDA 1 30,900 32,027 31,837 32,800 23,600 22,180 27,030 31,262
EBIT 1 26,065 26,669 25,780 24,860 14,923 13,125 17,494 21,464
Net income 1 19,715 20,022 20,338 10,067 3,656 10,255 13,674 16,493
Net Debt 1 -108,416 -103,741 -78,849 -64,899 -69,936 -57,862 -69,799 -75,671
Reference price 2 9,040.00 9,030.00 6,790.00 6,230.00 5,428.00 5,501.00 5,501.00 5,501.00
Nbr of stocks (in thousands) 77,923 72,015 74,203 74,339 74,339 74,339 - -
Announcement Date 2/4/22 A 2/14/23 A 2/9/24 A 2/10/25 A 2/10/26 A - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
20.82x4.02x14.67x3.08% 333B
17.63x2.66x11.75x3.62% 132B
24.53x3.67x15.44x2.35% 71.91B
42.62x6.87x29.8x2.16% 50.5B
19.76x2.77x11.58x4.5% 36.09B
81.57x2.42x14.56x1.67% 30.51B
22.86x1.67x10.71x2.24% 19.83B
20.1x1.28x8.35x1.31% 19.26B
15.49x1.5x8.56x3.41% 19.16B
Average 29.49x 2.98x 13.94x 2.71% 79.07B
Weighted average by Cap. 24.60x 3.60x 14.67x 2.99%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 4967 Stock
  4. KOY Stock
  5. Valuation Kobayashi Pharmaceutical Co., Ltd.